DAWN: Day One Biopharmaceuticals, Inc. Stock

by  •  • Comments Off on DAWN: Day One Biopharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,444.12
Enterprise Value ($M) 1,021.35
Book Value ($M) 555.46
Book Value / Share 5.51
Price / Book 2.60
NCAV ($M) 535.65
NCAV / Share 5.31
Price / NCAV 2.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 14.55
Current Ratio 14.62

Balance Sheet (mrq) ($M)
Current Assets 581.00
Assets 600.81
Liabilities 45.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A Atlas Venture Fund XI, L.P. 5.50 -19.48
11-07 13G Fmr Llc 7.54 86.80
08-05 13D/A AI Day1 LLC 13.15 0.00
02-14 13G/A Ra Capital Management, L.p. 9.00 10.93
02-13 13G Vanguard Group Inc 5.48
01-29 13G BlackRock, Inc. 5.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-06 10-Q f UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 582,793 1,547,233 37.67
2024-11-14 246,816 703,841 35.07
2024-11-13 279,325 937,309 29.80
2024-11-12 247,366 864,095 28.63

(click for more detail)

Similar Companies
CRNX – Crinetics Pharmaceuticals, Inc. CTMX – CytomX Therapeutics, Inc.
CYTK – Cytokinetics, Incorporated DNLI – Denali Therapeutics Inc.
DSGN – Design Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io